[3H]citalopram [Ligand Id: 4621] activity data from GtoPdb and ChEMBL
Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
| ChEMBL ligand: CHEMBL549 (Celexa, Citadur, Citalopram) |
|---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
| DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
|---|---|---|---|---|---|---|---|---|
| acetylcholinesterase (Cartwright blood group)/Acetylcholinesterase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL220] [GtoPdb: 2465] [UniProtKB: P22303] | ||||||||
| ChEMBL | Inhibition of human plasma AChE using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition and measured after 10 mins by Ellman's method | B | 4.13 | pIC50 | 73300 | nM | IC50 | Eur J Med Chem (2020) 198: 112368-112368 [PMID:32388114] |
| α1A-adrenoceptor/Alpha-1a adrenergic receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL319] [GtoPdb: 22] [UniProtKB: P43140] | ||||||||
| ChEMBL | DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin) | B | 6.15 | pKi | 711 | nM | Ki | DrugMatrix in vitro pharmacology data |
| ChEMBL | DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin) | B | 5.76 | pIC50 | 1756 | nM | IC50 | DrugMatrix in vitro pharmacology data |
| α1B-adrenoceptor/Alpha-1b adrenergic receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL315] [GtoPdb: 23] [UniProtKB: P15823] | ||||||||
| ChEMBL | DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) | B | 5.74 | pKi | 1820 | nM | Ki | DrugMatrix in vitro pharmacology data |
| ChEMBL | DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) | B | 5.48 | pIC50 | 3288 | nM | IC50 | DrugMatrix in vitro pharmacology data |
| α1D-adrenoceptor/Alpha-1d adrenergic receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL223] [GtoPdb: 24] [UniProtKB: P25100] | ||||||||
| ChEMBL | DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) | B | 5.79 | pKi | 1617 | nM | Ki | DrugMatrix in vitro pharmacology data |
| ChEMBL | DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) | B | 5.48 | pIC50 | 3289 | nM | IC50 | DrugMatrix in vitro pharmacology data |
| DAT/Dopamine transporter in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL238] [GtoPdb: 927] [UniProtKB: Q01959] | ||||||||
| ChEMBL | In vitro binding affinity against human dopamine transporter in dog kidney cell line by using [125I]RTI-55 radioligand | B | 4.78 | pKi | 16540 | nM | Ki | J. Med. Chem. (2004) 47: 1122-1135 [PMID:14971892] |
| DAT/Dopamine transporter in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2799] [GtoPdb: 927] [UniProtKB: Q61327] | ||||||||
| ChEMBL | Tested in vitro for dopamine(DA) neuronal uptake inhibition | B | 5 | pKi | >10000 | nM | Ki | J. Med. Chem. (1990) 33: 2793-2797 [PMID:2213832] |
| ChEMBL | Tested in vitro for serotonin(5-HT) neuronal uptake inhibition | B | 8.54 | pKi | 2.9 | nM | Ki | J. Med. Chem. (1990) 33: 2793-2797 [PMID:2213832] |
| DAT/Dopamine transporter in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL338] [GtoPdb: 927] [UniProtKB: P23977] | ||||||||
| ChEMBL | Displacement of [3H]GBR-12935 from dopamine transporter of rat caudate-putamen | B | 4.78 | pKi | 16540 | nM | Ki | Bioorg. Med. Chem. Lett. (2005) 15: 1131-1133 [PMID:15686927] |
| ChEMBL | Displacement of [3H]WIN-35428 from DAT in rat caudate-putamen by scintillation counting | B | 5.03 | pKi | 9270 | nM | Ki | J. Med. Chem. (2010) 53: 6112-6121 [PMID:20672825] |
| ChEMBL | Inhibition of dopamine uptake in rat synaptosomal fraction | F | 4.39 | pIC50 | 41000 | nM | IC50 | J. Med. Chem. (1985) 28: 1817-1828 [PMID:2999402] |
| Kv11.1/HERG in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL240] [GtoPdb: 572] [UniProtKB: Q12809] | ||||||||
| ChEMBL | DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole) | B | 4.86 | pKi | 13661.8 | nM | Ki | DrugMatrix in vitro pharmacology data |
| ChEMBL | DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole) | B | 4.78 | pIC50 | 16675.4 | nM | IC50 | DrugMatrix in vitro pharmacology data |
| ChEMBL | Inhibition of human Potassium channel HERG expressed in mammalian cells | B | 5.4 | pIC50 | 3981.07 | nM | IC50 | Bioorg. Med. Chem. Lett. (2003) 13: 2773-2775 [PMID:12873512] |
| ChEMBL | Inhibitory concentration against potassium channel HERG | B | 5.4 | pIC50 | 3981.07 | nM | IC50 | Bioorg. Med. Chem. Lett. (2005) 15: 2886-2890 [PMID:15911273] |
| ChEMBL | Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique | B | 5.4 | pIC50 | 3981.07 | nM | IC50 | Bioorg. Med. Chem. (2008) 16: 6252-6260 [PMID:18448342] |
| ChEMBL | Inhibition of human ERG | B | 5.4 | pIC50 | 3981.07 | nM | IC50 | Eur. J. Med. Chem. (2011) 46: 618-630 [PMID:21185626] |
| ChEMBL | Inhibition of human ERG | B | 8 | pIC50 | 10 | nM | IC50 | J. Med. Chem. (2013) 56: 8955-8971 [PMID:23919353] |
| H1 receptor/Histamine H1 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL231] [GtoPdb: 262] [UniProtKB: P35367] | ||||||||
| ChEMBL | DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine) | B | 6.43 | pKi | 371 | nM | Ki | DrugMatrix in vitro pharmacology data |
| ChEMBL | DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine) | B | 5.5 | pIC50 | 3194 | nM | IC50 | DrugMatrix in vitro pharmacology data |
| NET/Norepinephrine transporter in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL222] [GtoPdb: 926] [UniProtKB: P23975] | ||||||||
| ChEMBL | In vitro binding affinity against human norepinephrine transporter in human embryonic kidney cell line by using [3H]-nisoxatine radioligand | B | 5.21 | pKi | 6190 | nM | Ki | J. Med. Chem. (2004) 47: 1122-1135 [PMID:14971892] |
| ChEMBL | DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) | B | 5.66 | pKi | 2178 | nM | Ki | DrugMatrix in vitro pharmacology data |
| ChEMBL | DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) | B | 5.66 | pIC50 | 2196 | nM | IC50 | DrugMatrix in vitro pharmacology data |
| NET/Norepinephrine transporter in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2370] [GtoPdb: 926] [UniProtKB: O55192] | ||||||||
| ChEMBL | Tested in vitro for norepinephrine (NE) neuronal uptake inhibition | B | 6 | pKi | >1000 | nM | Ki | J. Med. Chem. (1990) 33: 2793-2797 [PMID:2213832] |
| Norepinephrine transporter in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL304] [UniProtKB: Q9WTR4] | ||||||||
| ChEMBL | Displacement of [3H]nisoxetine from norepinephrine transporter of rat cerebral cortex | B | 5.21 | pKi | 6190 | nM | Ki | Bioorg. Med. Chem. Lett. (2005) 15: 1131-1133 [PMID:15686927] |
| ChEMBL | Inhibition of noradrenaline uptake in rat synaptosomal fraction | F | 5.06 | pIC50 | 8800 | nM | IC50 | J. Med. Chem. (1985) 28: 1817-1828 [PMID:2999402] |
| 5-HT1A receptor/Serotonin 1a (5-HT1a) receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL273] [GtoPdb: 1] [UniProtKB: P19327] | ||||||||
| ChEMBL | Binding affinity of a compound to rat brain 5-hydroxytryptamine 1A (serotonin) receptor assayed by radiolabeled [3H]-8-OH-DPAT ligand displacement | B | 4.3 | pKi | 50118.72 | nM | Ki | J. Med. Chem. (1996) 39: 126-134 [PMID:8568799] |
| 5-HT2B receptor/Serotonin 2b (5-HT2b) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1833] [GtoPdb: 7] [UniProtKB: P41595] | ||||||||
| ChEMBL | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) | B | 5.93 | pKi | 1171 | nM | Ki | DrugMatrix in vitro pharmacology data |
| ChEMBL | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) | B | 5.74 | pIC50 | 1839 | nM | IC50 | DrugMatrix in vitro pharmacology data |
| 5-HT2C receptor/Serotonin 2c (5-HT2c) receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL225] [GtoPdb: 8] [UniProtKB: P28335] | ||||||||
| ChEMBL | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) | B | 6.81 | pKi | 156 | nM | Ki | DrugMatrix in vitro pharmacology data |
| ChEMBL | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) | B | 6.53 | pIC50 | 297 | nM | IC50 | DrugMatrix in vitro pharmacology data |
| SERT/Serotonin transporter in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL228] [GtoPdb: 928] [UniProtKB: P31645] | ||||||||
| GtoPdb | - | - | 8.3 | pKd | 5 | nM | Kd | |
| ChEMBL | Displacement of [3H]paroxetine from human SERT expressed in HEK293 cells | B | 7.48 | pKi | 32.8 | nM | Ki | Bioorg. Med. Chem. (2008) 16: 6364-6370 [PMID:18487050] |
| ChEMBL | Displacement of [3H]paroxetine from human SERT expressed in HEK293 cells | B | 7.48 | pKi | 32.8 | nM | Ki | Bioorg. Med. Chem. Lett. (2008) 18: 4727-4730 [PMID:18644726] |
| ChEMBL | Inhibition of [3H]5-HT uptake at human SERT expressed in COS7 cells after 3 mins by beta-counting | B | 7.8 | pKi | 16 | nM | Ki | Bioorg. Med. Chem. Lett. (2013) 23: 323-326 [PMID:23168018] |
| ChEMBL | Displacement of [3H]citalopram from human SERT expressed in HEK293 cells | B | 8.36 | pKi | 4.38 | nM | Ki | Bioorg. Med. Chem. (2008) 16: 6364-6370 [PMID:18487050] |
| ChEMBL | Displacement of [3H]citalopram from human SERT expressed in HEK293 cells | B | 8.36 | pKi | 4.38 | nM | Ki | Bioorg. Med. Chem. Lett. (2008) 18: 4727-4730 [PMID:18644726] |
| ChEMBL | Inhibition of SERT (unknown origin) | B | 8.8 | pKi | 1.6 | nM | Ki | J Med Chem (2020) 63: 15187-15217 [PMID:33111525] |
| ChEMBL | Inhibition of [125I]RTI-55 binding to human serotonin transporter expressed in human embryonic kidney cells | B | 8.8 | pKi | 1.6 | nM | Ki | J. Med. Chem. (2004) 47: 1122-1135 [PMID:14971892] |
| ChEMBL | DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) | B | 9.32 | pKi | 0.48 | nM | Ki | DrugMatrix in vitro pharmacology data |
| ChEMBL | Inhibition of SERT (unknown origin) assessed as inhibition of serotonin uptake | B | 4.05 | pIC50 | 90000 | nM | IC50 | J. Med. Chem. (2013) 56: 9709-9724 [PMID:24237160] |
| ChEMBL | Displacement of [3H]paroxetine from human SERT expressed in human HEK293 cells incubated for 30 mins by liquid scintillation counting analysis | B | 5.52 | pIC50 | 3000 | nM | IC50 | Eur J Med Chem (2020) 198: 112368-112368 [PMID:32388114] |
| ChEMBL | Inhibition of human wild type SERT expressed in COS7 cells assessed as inhibition of [3H]5HT uptake measured for 40 hrs by scintillation counting analysis | B | 7.23 | pIC50 | 59 | nM | IC50 | Eur J Med Chem (2021) 220: 113533-113533 [PMID:34049262] |
| ChEMBL | Inhibition of [3H]-serotonin reuptake at human SERT expressed in HEK293 cells after 15 to 20 mins by fluorescence neurotransmitter transporter assay | B | 7.72 | pIC50 | 19 | nM | IC50 | Bioorg. Med. Chem. (2011) 19: 1328-1348 [PMID:21227702] |
| ChEMBL | Antagonist activity at SERT receptor (unknown origin) by fluorescence based assay | B | 7.87 | pIC50 | 13.41 | nM | IC50 | Bioorg Med Chem Lett (2020) 30: 127027-127027 [PMID:32122737] |
| ChEMBL | Inhibition of [3H]5-HT uptake by SERT primary site (S1) (unknown origin) expressed in African green monkey COS1 cells after 10 mins by TopCount scintillation counting method | B | 8.17 | pIC50 | 6.7 | nM | IC50 | Bioorg Med Chem Lett (2017) 27: 470-478 [PMID:28041833] |
| ChEMBL | Inhibition of SERT (unknown origin) expressed in HEK293 cells assessed as reduction in 5-HT uptake incubated for 30 mins | B | 8.2 | pIC50 | 6.27 | nM | IC50 | Bioorg Med Chem (2018) 26: 3117-3125 [PMID:29729987] |
| ChEMBL | DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) | B | 9.04 | pIC50 | 0.9 | nM | IC50 | DrugMatrix in vitro pharmacology data |
| ChEMBL | Inhibition of [3H]-S-citalopram dissociation from SERT allosteric modulator site (S2) (unknown origin) expressed in African green monkey COS1 cell membranes by scintillation counting method | B | 5.06 | pEC50 | 8700 | nM | EC50 | Bioorg Med Chem Lett (2017) 27: 470-478 [PMID:28041833] |
| SERT/Serotonin transporter in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL313] [GtoPdb: 928] [UniProtKB: P31652] | ||||||||
| ChEMBL | Displacement of [3H]citalopram from SERT in rat brain stem by scintillation counting | B | 8.71 | pKi | 1.94 | nM | Ki | J. Med. Chem. (2010) 53: 6112-6121 [PMID:20672825] |
| ChEMBL | Displacement of [3H]paroxetine from serotonin transporter of rat cerebral cortex | B | 8.8 | pKi | 1.6 | nM | Ki | Bioorg. Med. Chem. Lett. (2005) 15: 1131-1133 [PMID:15686927] |
| ChEMBL | Inhibition of [3H]citalopram binding to Serotonin transporter of rat cerebral cortex | B | 8.82 | pKi | 1.5 | nM | Ki | Bioorg. Med. Chem. Lett. (2000) 10: 1559-1562 [PMID:10915050] |
| ChEMBL | Inhibition of SERT-mediated [3H]5HT uptake in rat synaptosomes by scintillation counting | B | 8.41 | pIC50 | 3.9 | nM | IC50 | J. Med. Chem. (2011) 54: 3206-3221 [PMID:21486038] |
| ChEMBL | Inhibition of [3H]5-HT reuptake at rat SERT expressed in HEK293 cells after 2 mins by liquid scintillation counting | B | 8.5 | pIC50 | 3.17 | nM | IC50 | Eur. J. Med. Chem. (2009) 44: 4862-4888 [PMID:19717215] |
| ChEMBL | Displacement of [3H]paroxetine from SERT in rat cortical membranes after 6 mins by liquid scintillation counting | B | 8.52 | pIC50 | 3 | nM | IC50 | Bioorg. Med. Chem. (2013) 21: 7604-7611 [PMID:24262884] |
| ChEMBL | Inhibition of 5-HT uptake in rat synaptosomal fraction | F | 8.74 | pIC50 | 1.8 | nM | IC50 | J. Med. Chem. (1985) 28: 1817-1828 [PMID:2999402] |
| σ2/Sigma intracellular receptor 2 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4105864] [GtoPdb: 2553] [UniProtKB: Q5U3Y7] | ||||||||
| ChEMBL | Displacement of [3H]DTG from sigma 2 receptor in Sprague-Dawley rat brain membranes in presence of (+)-pentazocine by scintillation counting method | B | 5.27 | pKi | 5410 | nM | Ki | J Med Chem (2020) 63: 15187-15217 [PMID:33111525] |
| sigma non-opioid intracellular receptor 1/Sigma opioid receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL287] [GtoPdb: 2552] [UniProtKB: Q99720] | ||||||||
| ChEMBL | DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) | B | 6.78 | pKi | 167 | nM | Ki | DrugMatrix in vitro pharmacology data |
| ChEMBL | DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) | B | 6.4 | pIC50 | 398 | nM | IC50 | DrugMatrix in vitro pharmacology data |
| sigma non-opioid intracellular receptor 1/Sigma opioid receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3602] [GtoPdb: 2552] [UniProtKB: Q9R0C9] | ||||||||
| ChEMBL | Displacement of [3H]-(+)-pentazocine from sigma 1 receptor in Sprague-Dawley rat brain membranes by scintillation counting method | B | 6.53 | pKi | 292 | nM | Ki | J Med Chem (2020) 63: 15187-15217 [PMID:33111525] |
| Organic cation transporter 1/Solute carrier family 22 member 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5685] [GtoPdb: 1019] [UniProtKB: O15245] | ||||||||
| ChEMBL | Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy | B | 4.73 | pIC50 | 18800 | nM | IC50 | J. Med. Chem. (2008) 51: 5932-5942 [PMID:18788725] |
| Transporter in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL6184] [UniProtKB: Q63380] | ||||||||
| ChEMBL | Displacement of [3H]nisoxetine from NET in rat frontal cortex by scintillation counting | B | 5.23 | pKi | 5950 | nM | Ki | J. Med. Chem. (2010) 53: 6112-6121 [PMID:20672825] |
| Cav1.2/Voltage-gated L-type calcium channel alpha-1C subunit in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3762] [GtoPdb: 529] [UniProtKB: P22002] | ||||||||
| ChEMBL | Inhibition of L-type calcium channel measured using whole-cell patch clamp in rat ventricular myocytes | F | 4.19 | pIC50 | 64500 | nM | IC50 | Journal of Applied Toxicology (2012) 32: 858-866 [PMID:22761000] |
ChEMBL data shown on this page come from version 31:
Gaulton A, Hersey A, Nowotka M, Bento AP, Chambers J, Mendez D, Mutowo P, Atkinson F, Bellis LJ, Cibrián-Uhalte E, Davies M, Dedman N, Karlsson A, Magariños MP, Overington JP, Papadatos G, Smit I, Leach AR. (2017) 'The ChEMBL database in 2017.' Nucleic Acids Res., 45(D1). DOI: 10.1093/nar/gkw1074. [PMCID:5210557]
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License